Hodgkin lymphoma treatment & prognosis in children — what every parent needs to know
Medically reviewed by the CION Paediatric Oncology Team · Last reviewed June 2026
Your child has been diagnosed with Hodgkin lymphoma. This page explains — in plain language — what the disease is, how treatment works, what hodgkin chemo and radiation actually involve, and what prognosis means in your child's individual case. You deserve clear answers, not a Google spiral.
- Hodgkin lymphoma is highly treatable — it is one of the most treatable cancers in paediatric oncology
- Tumour board for every child — haematologist, paediatric oncologist, and radiation specialist together from Day 1
- 45-minute consultations — no rushed decisions, every question answered, transparent treatment roadmap
- 17 specialist oncologists across 35+ CION centres in Telangana & Andhra Pradesh
on Panel
Survival Rate*
Treated
(800+ reviews)
What is Hodgkin lymphoma — and why is it treated differently in children?
Hodgkin lymphoma is a cancer of the lymphatic system — the network of glands and vessels that forms part of your child's immune defence. It is defined by the presence of a specific abnormal cell, called the Reed-Sternberg cell, found in a lymph node biopsy. That single microscopic finding is what separates Hodgkin lymphoma from all other lymphomas.
The lymphatic system runs throughout the entire body, so lymphoma can involve lymph nodes in the neck, chest, armpits, abdomen, and groin. The most common way it first shows itself is as a painless, firm swelling in the neck — often noticed by a parent while bathing or dressing a child, or by the child themselves. Sometimes the only sign is persistent fatigue, night sweats, or unexplained weight loss — the "B symptoms" that oncologists look for.
Hodgkin lymphoma in children behaves differently from the same diagnosis in adults. The disease biology, the treatment protocols, and the outcomes differ significantly between paediatric and adult cases. This is why your child must be managed by a team that has specific experience with childhood lymphoma — not simply a general oncologist. Paediatric Hodgkin lymphoma protocols have been refined over decades through large international clinical studies, and the established treatment approach reflects that accumulated knowledge.
The question every parent asks first is: "Is there any hope?" We will not give you empty reassurance. What we will tell you is that Hodgkin lymphoma in children is, in the words of specialist paediatric oncology guidelines, one of the most treatable cancers in childhood. That does not make the journey easy. It does mean that with the right team and the right protocol, the path forward is clear — and we walk it with you.
Did you know?
Hodgkin lymphoma is the most common lymphoma in adolescents and young adults, with a second, smaller peak occurring in younger children. Unlike many other childhood cancers, Hodgkin lymphoma has internationally established treatment protocols that have been used in large paediatric clinical studies for more than 40 years — giving oncologists a well-understood roadmap for managing the disease at every stage. (Source: ICMR Cancer in India Report; WHO Classification of Haematopoietic Tumours)
Hodgkin lymphoma subtypes — what the pathology report means
The biopsy report will name a specific subtype of Hodgkin lymphoma. Each subtype reflects a different microscopic appearance of the tumour cells. Your oncologist uses the subtype — alongside stage and other factors — to shape the treatment plan. Here is what each subtype means in plain language.
Nodular Sclerosis (NSHL)
The most frequently diagnosed subtype in adolescents and young adults. It is named after the bands of fibrous tissue (sclerosis) visible on the biopsy slide. NSHL most often involves lymph nodes in the upper chest (mediastinum) and neck. It follows the standard Hodgkin lymphoma treatment pathway.
Mixed Cellularity (MCHL)
More common in younger children than in teenagers. The microscopic appearance shows Reed-Sternberg cells surrounded by a mixture of different normal immune cells. MCHL is more likely to involve lymph nodes in the abdomen and may present at a more advanced stage, but it responds well to established treatment protocols.
Lymphocyte-Rich (LRHL)
A less common subtype with a high proportion of normal lymphocytes around the Reed-Sternberg cells. It tends to present at an earlier stage and follows a favourable clinical course. Treatment follows the same general Hodgkin lymphoma protocol, often at lower intensity due to the typically limited extent of disease.
Lymphocyte-Depleted (LDHL)
The rarest classical subtype. It is more likely to be diagnosed at an advanced stage and involves fewer normal lymphocytes around the Reed-Sternberg cells. Despite its more advanced presentation, it is still managed with established Hodgkin lymphoma protocols and responds to treatment.
Nodular Lymphocyte Predominant (NLPHL)
Technically a separate entity from classical Hodgkin lymphoma, though treated under the Hodgkin lymphoma umbrella. The abnormal cells in NLPHL look different from Reed-Sternberg cells and are called "popcorn cells." NLPHL often presents at a very early stage and may be managed with a less intensive protocol. Your oncologist will explain if this subtype changes the treatment approach.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a team that reviews every decision together
At CION, every child with Hodgkin lymphoma goes to a tumour board — medical, surgical, and radiation oncologists reviewing the same evidence together. No single-doctor decisions. No unnecessary tests. Decisions for healing, not billing.
How Hodgkin lymphoma treatment works in children — step by step
Hodgkin lymphoma treatment is structured and sequential. Understanding each step before it happens helps parents prepare, ask the right questions, and feel less overtaken by events.
-
Staging — mapping how far the lymphoma has spread
Before any treatment begins, the oncology team needs to know which lymph node regions are affected and whether the lymphoma has reached organs such as the spleen, liver, lungs, or bone marrow. This is called staging. A CT scan or PET scan — or a combination of both — is used to produce a detailed map of the disease. The lymphoma is then assigned a stage (I to IV) based on how many regions are involved and whether disease is present on one side or both sides of the diaphragm. The stage, together with other factors, directly determines the intensity and duration of the treatment plan.
-
Chemotherapy cycles — the core of Hodgkin lymphoma treatment
Chemotherapy is the foundation of Hodgkin lymphoma treatment in children. It is given in cycles — a period of treatment followed by a rest period to allow blood counts to recover — repeated over several months. Treatment is given as a day procedure through a drip, usually in a paediatric day-care oncology unit, so children can return home the same day. The number of cycles depends on the stage and risk classification of the disease. Your child's oncologist will explain the planned number of cycles and the length of the full chemotherapy course at the treatment planning consultation, so you have a clear timeline before you begin.
-
Interim response assessment — how the lymphoma is responding
After the first two to three cycles of chemotherapy, an interim scan (usually a PET scan) is performed. This is one of the most important moments in the treatment course: it shows whether the lymphoma is responding to treatment as expected. A good early response — called an early complete metabolic response — is a very positive sign and may allow the treatment intensity to be reduced or the planned radiation component to be omitted entirely. A partial response may lead to an increase in treatment intensity. This response-adapted approach tailors treatment to your child's actual response rather than applying the same plan to every child regardless of how they are doing.
-
Radiation therapy — when it is added and why
Radiation therapy to the lymph node regions where Hodgkin lymphoma was found is used in some — but not all — children. The decision depends on the stage, the subtype, the interim scan result, and the child's age. In younger children, oncologists aim to use as little radiation as possible to minimise late effects on growing bone and tissue. When radiation is needed, modern techniques deliver it precisely to the affected areas while sparing surrounding healthy tissue as much as possible. Your radiation oncologist will explain the specific fields, the number of sessions, and what to expect during and after the course.
-
End-of-treatment evaluation and follow-up planning
When the planned treatment course is complete, a final scan is performed to confirm the response. If no lymphoma is detectable — a complete response — the team moves to a structured follow-up schedule: regular clinic visits and blood tests at decreasing intervals over the following years. The purpose of follow-up is to detect any relapse early, monitor for late effects of treatment, and support your child's return to normal life. The team will give you a written follow-up plan so you know exactly what appointments are needed and when. Follow-up care at CION includes psycho-oncology support and nutritional guidance alongside the clinical reviews.
Want to understand your child's specific treatment plan?
A 45-minute consultation with a CION paediatric oncologist will walk you through the staging results and the exact treatment sequence planned for your child — cycle by cycle, in plain language.
What does "prognosis" mean for your child — and how does CION approach it?
Prognosis is not a single number. It is a picture assembled from your child's specific case — the stage of the disease, the subtype, how it is responding, and the features of your child's overall health. A parent asking "what is the hodgkin cure rate in children?" deserves a direct answer about their child, not a population average.
The factors the oncology team considers when discussing prognosis include: stage at diagnosis (earlier stages carry a more favourable outlook than advanced stages); the presence or absence of B symptoms (fever, night sweats, weight loss — their presence indicates a more active disease process); the subtype (some subtypes have a more favourable behaviour than others); and critically, how the lymphoma responds to the first two to three cycles of chemotherapy, as measured on the interim PET scan.
The interim scan result is one of the most powerful prognostic signals in childhood Hodgkin lymphoma. A complete metabolic response — meaning no detectable lymphoma activity on the interim scan — tells the team that the disease is highly sensitive to the chosen treatment. This information shapes the remainder of the treatment plan and is a genuinely encouraging finding.
We will not give you a percentage and send you home to search what it means. At every stage, your CION oncologist will sit with you — for as long as you need — and explain what the results show, what they mean for your child's specific situation, and what the next step is. Decisions for healing, not billing. No rushed conversations. You deserve the time it takes to truly understand.
If a relapse occurs — which we will monitor for closely in the follow-up period — it does not mean treatment has failed permanently. Salvage protocols exist for relapsed Hodgkin lymphoma in children, and the oncology team will explain the available approaches if and when that situation arises. We prepare for every possibility, and we face each stage with you, together.
15,000+ families have trusted CION — we walk this journey with you
Hear from other parents who sat in the same place of uncertainty. A tumour board reviewed their child's case. A specialist explained every step. A treatment plan was built around their child's response.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Your questions about Hodgkin lymphoma in children — answered
What is Hodgkin lymphoma and how is it different from non-Hodgkin lymphoma?
Hodgkin lymphoma (HL) is a cancer of the lymphatic system that is defined by the presence of a specific abnormal cell called the Reed-Sternberg cell. When a pathologist finds Reed-Sternberg cells in a lymph node biopsy, the diagnosis is Hodgkin lymphoma. Non-Hodgkin lymphoma (NHL) is a broad group of other lymph gland cancers that do not contain Reed-Sternberg cells. The distinction matters because HL and NHL behave differently, respond to different treatment protocols, and have different prognoses. In children and young people, Hodgkin lymphoma is known for responding particularly well to treatment — specialist oncology teams have well-established protocols that have been refined over many decades specifically for this disease.
How is Hodgkin lymphoma diagnosed in a child?
Diagnosis begins with a thorough physical examination and blood tests. If a swollen lymph node has been present for more than two to three weeks — especially in the neck, collarbone, armpit, or groin — the doctor will usually request an ultrasound first, then a CT or PET scan to map how many lymph node areas are affected and whether the disease has spread to areas such as the spleen, liver, or bone marrow. The definitive diagnosis comes from a lymph node biopsy: a small sample of tissue is removed and examined under a microscope by a pathologist. A finding of Reed-Sternberg cells confirms Hodgkin lymphoma. The biopsy is done under sedation or general anaesthesia in children so the procedure is not distressing.
What does Hodgkin lymphoma treatment in children involve?
Treatment of Hodgkin lymphoma in children typically combines chemotherapy — medicines given through a drip or by mouth over several cycles — with radiation therapy in some cases. Chemotherapy is used in virtually all cases. Radiation therapy to the areas where lymphoma was found may be added depending on how the lymphoma has responded to the initial chemotherapy cycles. The decision on whether and how much radiation to include depends on the stage of the disease, the child's age, and how well the lymphoma has responded after the first treatment cycles. A multidisciplinary tumour board reviews each child's case to plan the right combination. Treatment is given in cycles, with rest periods between, so the body can recover.
What is the prognosis for a child with Hodgkin lymphoma?
Hodgkin lymphoma in children and young people is one of the cancers with the most encouraging prognoses in paediatric oncology, and specialist guidelines worldwide regard it as a highly treatable disease. Prognosis depends on several factors: the stage of the disease at diagnosis (how many areas of the body are affected), whether B symptoms are present, the specific subtype, and how well the lymphoma responds to the first cycles of treatment. The oncology team will discuss your child's individual case in detail after biopsy and imaging results are complete. We will not give you general percentages that may not apply to your child's situation — we will explain what the specific features of your child's disease mean for their treatment plan.
Will my child lose their hair during Hodgkin lymphoma treatment?
Hair thinning or loss is possible during Hodgkin lymphoma treatment, though it varies between children depending on which treatment protocol is used. It is almost always temporary — hair begins to regrow once treatment is complete, usually within a few months of finishing, sometimes with a change in texture or curl. The care team will prepare you and your child honestly for what is likely with the specific protocol planned. Practical resources — head coverings, scalp care, normalising conversations with siblings and schoolmates — are part of the psycho-oncology and nursing support CION provides alongside clinical treatment.
Can my child go to school during Hodgkin lymphoma treatment?
Many children with Hodgkin lymphoma can attend school for at least part of their treatment course, particularly during the rest weeks between chemotherapy cycles when blood counts have recovered. Whether school attendance is safe on any given day depends on your child's white cell count — the care team will give you a simple guide to the count thresholds that indicate a safe day versus a stay-home day. Schools should be informed of the diagnosis so that outbreaks of infections such as chickenpox (which can be more serious in immunocompromised children) are notified to you immediately. Maintaining social connection and routine is genuinely good for children's wellbeing during a long treatment course — the team will actively support as normal a life as possible.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.